| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |